Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy — Stella

Home/Myoma;Uterus/Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy

View on ClinicalTrials.gov

Recruiting

Back to Myoma;Uterus trials

Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Egypt

Fayoum University, Al Fayyum, Faiyum Governorate

Key details

Sponsor

Cairo University

Collaborators

Kafrelsheikh University

Enrollment target

~40 participants

Started

January 2026

Primary completion

July 2026

Age range

25 Years – 48 Years

Sex

Female only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.